Cvs Health Corporation (CVS)

$61

+2.35

(+4.01%)▲

Market is closed - opens 7 PM, 29 Jul 2024
star icon

CVS Health Corp is a healthcare company that operates a retail pharmacy chain and provides a range of healthcare services and products.

Performance

  • $59.04
    $61.07
    $61.00
    downward going graph

    3.21%

    Downside

    Day's Volatility :3.32%

    Upside

    0.11%

    downward going graph
  • $52.18
    $80.80
    $61.00
    downward going graph

    14.46%

    Downside

    52 Weeks Volatility :35.42%

    Upside

    24.5%

    downward going graph

Returns

PeriodCvs Health CorporationSector (Health Care)S&P500
3 Months
-12.7%
6.5%
5.9%
6 Months
-19.66%
7.1%
10.4%
1 Year
-21.9%
9.8%
18.2%
3 Years
-29.23%
14.2%
22.1%

Highlights

Market Capitalization
73.5B
Book Value
$59.08
Dividend Share
2.48
Dividend Yield
4.54%
Earnings Per Share (EPS)
5.7
PE Ratio
10.27
PEG Ratio
1.0
Wall Street Target Price
61.57
Profit Margin
2.04%
Operating Margin TTM
2.13%
Return On Assets TTM
3.18%
Return On Equity TTM
10.09%
Revenue TTM
359.7B
Revenue Per Share TTM
281.15
Quarterly Revenue Growth YOY
3.5999999999999996%
Gross Profit TTM
53.5B
EBITDA
16.9B
Diluted Eps TTM
5.7
Quarterly Earnings Growth YOY
-0.47
EPS Estimate Current Year
6.43
EPS Estimate Next Year
7.19
EPS Estimate Current Quarter
1.69
EPS Estimate Next Quarter
2.19

Analyst Recommendation

Buy
    66%Buy
    33%Hold
    0
    0%Sell
Based on 33 Wall street analysts offering stock ratings for Cvs Health Corporation(by analysts ranked 0 to 5 stars)
Based on 33 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
22
22
22
Hold
11
11
9
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 0.93%

Current $61.00
Target $61.57

Company Financials

FY18Y/Y Change
Revenue
194.6B
↑ 5.31%
Net Income
-594.0M
↓ 108.97%
Net Profit Margin
-0.31%
↓ 3.89%
FY19Y/Y Change
Revenue
256.8B
↑ 31.96%
Net Income
6.6B
↓ 1216.84%
Net Profit Margin
2.58%
↑ 2.89%
FY20Y/Y Change
Revenue
268.7B
↑ 4.65%
Net Income
7.2B
↑ 8.22%
Net Profit Margin
2.67%
↑ 0.09%
FY21Y/Y Change
Revenue
292.1B
↑ 8.71%
Net Income
8.0B
↑ 11.45%
Net Profit Margin
2.74%
↑ 0.07%
FY22Y/Y Change
Revenue
322.5B
↑ 10.39%
Net Income
4.3B
↓ 46.12%
Net Profit Margin
1.34%
↓ 1.4%
FY23Y/Y Change
Revenue
357.8B
↑ 10.95%
Net Income
8.3B
↑ 93.55%
Net Profit Margin
2.33%
↑ 0.99%
Q4 FY22Q/Q Change
Revenue
83.8B
↑ 3.31%
Net Income
2.3B
↓ 167.53%
Net Profit Margin
2.75%
↑ 6.95%
Q1 FY23Q/Q Change
Revenue
85.3B
↑ 1.71%
Net Income
2.1B
↓ 7.21%
Net Profit Margin
2.5%
↓ 0.25%
Q2 FY23Q/Q Change
Revenue
88.9B
↑ 4.27%
Net Income
1.9B
↓ 11.0%
Net Profit Margin
2.14%
↓ 0.36%
Q3 FY23Q/Q Change
Revenue
89.8B
↑ 0.95%
Net Income
2.3B
↑ 18.94%
Net Profit Margin
2.52%
↑ 0.38%
Q4 FY23Q/Q Change
Revenue
93.8B
↑ 4.51%
Net Income
2.0B
↓ 9.51%
Net Profit Margin
2.18%
↓ 0.34%
Q1 FY24Q/Q Change
Revenue
88.4B
↓ 5.73%
Net Income
1.1B
↓ 45.6%
Net Profit Margin
1.26%
↓ 0.92%
FY18Y/Y Change
Total Assets
196.5B
↑ 106.51%
Total Liabilities
137.9B
↑ 140.12%
FY19Y/Y Change
Total Assets
222.4B
↑ 13.23%
Total Liabilities
158.3B
↑ 14.77%
FY20Y/Y Change
Total Assets
230.7B
↑ 3.72%
Total Liabilities
161.0B
↑ 1.73%
FY21Y/Y Change
Total Assets
233.0B
↑ 0.99%
Total Liabilities
157.6B
↓ 2.11%
FY22Y/Y Change
Total Assets
228.3B
↓ 2.03%
Total Liabilities
157.0B
↓ 0.42%
FY23Y/Y Change
Total Assets
249.7B
↑ 9.4%
Total Liabilities
173.1B
↑ 10.28%
Q4 FY22Q/Q Change
Total Assets
228.3B
↓ 1.27%
Total Liabilities
157.0B
↓ 2.02%
Q1 FY23Q/Q Change
Total Assets
239.3B
↑ 4.84%
Total Liabilities
167.8B
↑ 6.87%
Q2 FY23Q/Q Change
Total Assets
250.1B
↑ 4.49%
Total Liabilities
177.1B
↑ 5.56%
Q3 FY23Q/Q Change
Total Assets
251.3B
↑ 0.49%
Total Liabilities
176.8B
↓ 0.15%
Q4 FY23Q/Q Change
Total Assets
249.7B
↓ 0.63%
Total Liabilities
173.1B
↓ 2.1%
Q1 FY24Q/Q Change
Total Assets
249.7B
↑ 0.01%
Total Liabilities
175.6B
↑ 1.44%
FY18Y/Y Change
Operating Cash Flow
8.9B
↑ 10.72%
Investing Cash Flow
-43.3B
↑ 1376.3%
Financing Cash Flow
36.8B
↓ 645.39%
FY19Y/Y Change
Operating Cash Flow
12.8B
↑ 44.93%
Investing Cash Flow
-3.3B
↓ 92.29%
Financing Cash Flow
-7.9B
↓ 121.32%
FY20Y/Y Change
Operating Cash Flow
15.9B
↑ 23.48%
Investing Cash Flow
-5.5B
↑ 65.74%
Financing Cash Flow
-8.2B
↑ 3.89%
FY21Y/Y Change
Operating Cash Flow
18.3B
↑ 15.13%
Investing Cash Flow
-5.3B
↓ 4.93%
Financing Cash Flow
-11.4B
↑ 39.25%
FY22Y/Y Change
Operating Cash Flow
16.2B
↓ 11.43%
Investing Cash Flow
-5.0B
↓ 4.07%
Financing Cash Flow
-10.5B
↓ 7.4%
Q4 FY22Q/Q Change
Operating Cash Flow
-2.0B
↓ 121.4%
Investing Cash Flow
-119.0M
↓ 97.59%
Financing Cash Flow
-2.2B
↓ 32.04%
Q1 FY23Q/Q Change
Operating Cash Flow
7.4B
↓ 481.05%
Investing Cash Flow
-8.5B
↑ 7054.62%
Financing Cash Flow
2.7B
↓ 224.65%
Q2 FY23Q/Q Change
Operating Cash Flow
5.9B
↓ 20.57%
Investing Cash Flow
-10.4B
↑ 21.71%
Financing Cash Flow
3.6B
↑ 33.02%
Q3 FY23Q/Q Change
Operating Cash Flow
2.7B
↓ 54.03%
Investing Cash Flow
-19.6B
↑ 89.61%
Financing Cash Flow
-2.7B
↓ 174.38%

Technicals Summary

Sell

Neutral

Buy

Cvs Health Corporation is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cvs Health Corporation
Cvs Health Corporation
-3.27%
-19.66%
-21.9%
-29.23%
5.6%
The Cigna Corp
The Cigna Corp
1.06%
14.55%
17.36%
49.34%
103.92%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
15.63%
11.22%
10.17%
35.34%
121.27%
Humana Inc.
Humana Inc.
7.01%
6.97%
-13.79%
-17.31%
39.56%
Elevance Health, Inc
Elevance Health, Inc
-3.8%
6.25%
9.46%
35.81%
71.35%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cvs Health Corporation
Cvs Health Corporation
10.27
10.27
1.0
6.43
0.1
0.03
0.05
59.08
The Cigna Corp
The Cigna Corp
28.1
28.1
0.89
28.5
0.09
0.03
0.02
144.9
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
37.05
37.05
1.24
25.54
0.16
0.07
0.02
102.02
Humana Inc.
Humana Inc.
23.82
23.82
1.64
16.34
0.12
0.05
0.01
133.86
Elevance Health, Inc
Elevance Health, Inc
18.22
18.22
1.14
37.26
0.17
0.06
0.01
181.94
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cvs Health Corporation
Cvs Health Corporation
Buy
$73.5B
5.6%
10.27
2.04%
The Cigna Corp
The Cigna Corp
Buy
$97.2B
103.92%
28.1
1.77%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$515.2B
121.27%
37.05
3.66%
Humana Inc.
Humana Inc.
Buy
$46.5B
39.56%
23.82
1.82%
Elevance Health, Inc
Elevance Health, Inc
Buy
$120.8B
71.35%
18.22
3.9%

Insights on Cvs Health Corporation

  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 93.81B → 88.43B (in $), with an average decrease of 5.7% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 2.26B → 1.11B (in $), with an average decrease of 27.6% per quarter

  • Vs CI

    In the last 1 year, The Cigna Corp has given 17.4% return, outperforming this stock by 39.3%

  • Vs CI

    In the last 3 years, The Cigna Corp has given 49.3% return, outperforming this stock by 78.5%

Institutional Holdings

  • Vanguard Group Inc

    9.25%

  • BlackRock Inc

    6.94%

  • State Street Corporation

    4.38%

  • Capital World Investors

    3.49%

  • Dodge & Cox

    3.27%

  • Capital Research & Mgmt Co - Division 3

    3.02%

Corporate Announcements

  • Cvs Health Corporation Dividends March,2024

    In the quarter ending March,2024. Cvs Health Corporation has declared dividend of $0.67

    Read More

Company Information

CVS Health Corporation is an American healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands.

Organization
Cvs Health Corporation
Employees
219000
CEO
Ms. Karen Sue Lynch
Industry
Retail Trade

Discover More

FAQs